middle.news
TrivarX Secures $4.2M to Acquire Breakthrough Brain Tumor Imaging Tech
9:34am on Thursday 16th of October, 2025 AEDT
•
Healthcare
Read Story
TrivarX Secures $4.2M to Acquire Breakthrough Brain Tumor Imaging Tech
9:34am on Thursday 16th of October, 2025 AEDT
Key Points
Acquisition of Stabl-Im brain tumor imaging IP from Nucleics
Technology enables early, safe detection of brain metastases via standard MRI
$4.2 million placement led by Dr Daniel Tillett as cornerstone investor
Phase 1 clinical trial planned for 2026 to validate safety and imaging precision
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE